Identification and external validation of a prognostic signature based on N6-methyladenosine- and tertiary lymphoid structures-related genes to evaluate survival prognosis and treatment efficacy in lung adenocarcinoma
Abstract Background The N6-Methyladenosine (m6A) RNA modification critically regulates cancer biology, and tertiary lymphoid structures (TLSs) shape antitumor immunity. However, their combined prognostic roles in lung adenocarcinoma (LUAD) remain unclear. This study applies an integrative multi-omic...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer
2025-12-01
|
| Edice: | Discover Oncology |
| Témata: | |
| On-line přístup: | https://doi.org/10.1007/s12672-025-04318-w |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
